Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04065685Not ApplicableWithdrawn

A Nurse-led Patient-centred Intervention to Increase Written Advance Directives

Role: collaborator

NCT05873309Completed

The Role of OXytocin in Acute Ischemic Stroke reconvAlesceNcE: The ROXANE Study

Role: collaborator

NCT03038841Unknown

Mobile Health Technology for Palliative Care Patients

Role: collaborator

NCT00801099Not ApplicableCompleted

Benefit of a Single Preoperative Dose of Antibiotics for the Prevention of Surgical Site Infections

Role: collaborator

NCT00603928Completed

Placebo Interventions in General Practice

Role: collaborator

All 5 trials loaded